Taysha Gene Therapies Inc.

NASDAQ: TSHA
Share price (8/15/25): $2.94
Market cap (8/15/25): $802 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Ra Capital Management, L.P.

Rtw Investments, LP

News Filter

Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Natural History Data Analysis Established Patients ≥ Six Years of Age Are in Developmental Plateau, With a ~0% Likelihood of Gaining/Regaining Developmental Milestones Across the Core Functional Domains of Rett Syndrome

Natural History Data Analysis Established Patients ≥ Six Years of Age Are in Developmental Plateau, With a ~0% Likelihood of Gaining/Regaining Developmental Milestones Across the Core Functional Domains of Rett Syndrome

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC